Status: current, Defined. Date: 28-Feb 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4784081000168116 | Olamlo HCT 20/5/12.5 (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4784091000168118 | Olamlo HCT 20/5/12.5 tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Olamlo HCT 20/5/12.5 tablet, 30 | has TPUU | True | Olamlo HCT 20/5/12.5 tablet | Inferred relationship | Some | 1834729676 |
Olamlo HCT 20/5/12.5 tablet, 30, blister pack | has TPUU | True | Olamlo HCT 20/5/12.5 tablet | Inferred relationship | Some | 938816752 |
Olamlo HCT 20/5/12.5 tablet, 10 | has TPUU | True | Olamlo HCT 20/5/12.5 tablet | Inferred relationship | Some | 1417364846 |
Olamlo HCT 20/5/12.5 tablet, 10, blister pack | has TPUU | True | Olamlo HCT 20/5/12.5 tablet | Inferred relationship | Some | 191244657 |
Reference Sets
Trade product unit of use reference set